TMCNet:  Research and Markets: Global NGS (Next Generation Sequencing) Report to 2015

[February 07, 2014]

Research and Markets: Global NGS (Next Generation Sequencing) Report to 2015

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Global NGS (Next Generation Sequencing) Report to 2015" report to their offering.

This second edition of the NGS report highlights two key topics, emerging adoption of NGS in clinical settings, as we expect 2015 to an inflection point for this market segment and the continued decentralization driven by desktop sequencers.

Next generation sequencing (NGS) is a disruptive technology that allows scientists to sequence and assemble millions to billions of short DNA reads. This technology is used for applications such as whole genome sequencing, whole exome sequencing (1-2% of the genome that actually encodes proteins) or expression profiling. NGS is the fastest growing and the most attractive segment of the $7.1B genomics space (manufacturer market). With an estimated market size of -$1.2B in 2012, and a double digit growth rate, we forecast this market will reach $2.1B in 2015, driven by adoption in non-academic customers, especially clinical customers. NGS is poised to revolutionize not only medical research in academic laboratories and Biopharma, but also the healthcare landscape and applied markets (e.g., AgBio, food testing). The second edition of this report reviews the market size, segmentation, growth and trends of the NGS (and third generation sequencing) market.

p> We assess the NGS market across 5 segments: company (Illumina, Life Technologies (Ion Torrent), Roche / 454 Life Sciences, Pacific BioSciences, and Others), product type (Instrument, Reagents, Services), customer (Academia, Biopharma, Applied Markets, Clinical, Other), instrument type (Workhorse, Desktop) and geography (U.S., Europe, Japan, Asia/Pacific, Others). For each of these segments, we provide an annual market size and growth from 2009 to 2015, as well as key growth drivers and moderators.

In addition, we review major factors driving future growth including:

  • 1) Increased reagent usage on an expanding instrument installed base
  • 2) Continued decentralization via desktop sequencers such as Illumina's MiSeq that make the technology accessible to individual academic laboratories and in clinical settings
  • 3) Increased adoption of the technology by new customers (e.g., Applied markets such as AgBio, patients in clinical trials)
  • 4) Increased usage for new scientific applications beyond pure sequencing (e.g., expression profiling, ChIP-Seq, methylation studies)
  • 5) Broader adoption of sequencing services (e.g., BGI/Complete Genomics).

On the other hand, we discuss four key factors moderating growth including

  • 1) Increasing pricing pressure driven by more affordable instrument options and continued technological improvements leading to cheaper cost per base pair and technology commoditization
  • 2) Increasing use of service providers offering an alternative to in-house platform adoption, as many customers don't have the budget for / interest in large capital expenditures for such fast-evolving technologies
  • 3) Continuing workflow and bioinformatics issues, especially for more translational applications
  • 4) Continuing unfavorable research funding dynamics in the U.S. - especially in light of budget sequestration - and abroad.

Key Topics Covered:




What's new

Context and methodology

Genomics market overview


Market overview


Market size and growth by product type

Market size and growth by instrument type

Market size and growth by company

Market size and growth by customer base

Market size and growth by geography

Technology trends in genomics use



Life Technologies / Ion Torrent

Roche / 454 Life Sciences

Pacific Biosciences

BGI / Complete Genomics




For more information visit

[ Back To NFVZone's Homepage ]